Sai Life Sciences Faces ₹32.6 Million Tax Penalty Amid Compliance Scrutiny

Sai Life Sciences Ltd has been penalized ₹32.6 million in tax dues, reflecting regulatory scrutiny on pharma firms. While the penalty is notable, it is not expected to materially impact operations. The company is reviewing the order and may pursue remedies, underscoring the importance of compliance in India’s life sciences sector.

Show more

Stay Ahead – Explore Now! Sonata Software’s ₹1.09 Billion Q1 Profit Sparks Dividend Windfall in a Cautious Tech Climate